{
    "id": 27937,
    "fullName": "ROR2 positive",
    "impact": "unknown",
    "proteinEffect": "unknown",
    "geneVariantDescriptions": [
        {
            "description": "ROR2 positive indicates the presence of the ROR2 gene, mRNA, and/or protein.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "non-specific",
    "gene": {
        "id": 4920,
        "geneSymbol": "ROR2",
        "terms": [
            "ROR2",
            "BDB",
            "BDB1",
            "NTRKR2"
        ]
    },
    "variant": "positive",
    "createDate": "04/30/2018",
    "updateDate": "02/22/2019",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 13823,
            "approvalStatus": "Preclinical - Cell line xenograft",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, BA3021 (CAB-ROR2-ADC) inhibited growth of Ror2-positive melanoma cells in culture and in cell line xenograft models (Proceedings of the AACR, Apr 2018, Vol 59, Abstract 833).",
            "molecularProfile": {
                "id": 29507,
                "profileName": "ROR2 positive"
            },
            "therapy": {
                "id": 6906,
                "therapyName": "BA3021",
                "synonyms": null
            },
            "indication": {
                "id": 1909,
                "name": "melanoma",
                "source": "DOID"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 11293,
                    "pubMedId": null,
                    "title": "Anti-tumor efficacy of BA3021, a novel Conditionally Active Biologic (CAB) anti-ROR2 ADC",
                    "url": "https://cancerres.aacrjournals.org/content/78/13_Supplement/833"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 13821,
            "approvalStatus": "Preclinical - Cell line xenograft",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, BA3021 (CAB-ROR2-ADC) inhibited growth of Ror2-positive lung cancer cells in culture and in cell line xenograft models (Proceedings of the AACR, Apr 2018, Vol 59, Abstract 833).",
            "molecularProfile": {
                "id": 29507,
                "profileName": "ROR2 positive"
            },
            "therapy": {
                "id": 6906,
                "therapyName": "BA3021",
                "synonyms": null
            },
            "indication": {
                "id": 1324,
                "name": "lung cancer",
                "source": "DOID"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 11293,
                    "pubMedId": null,
                    "title": "Anti-tumor efficacy of BA3021, a novel Conditionally Active Biologic (CAB) anti-ROR2 ADC",
                    "url": "https://cancerres.aacrjournals.org/content/78/13_Supplement/833"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 13824,
            "approvalStatus": "Preclinical - Pdx & cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, BA3021 (CAB-ROR2-ADC) inhibited growth of Ror2-positive sarcoma cells in culture, and in both cell line and patient-derived xenograft models (Proceedings of the AACR, Apr 2018, Vol 59, Abstract 833).",
            "molecularProfile": {
                "id": 29507,
                "profileName": "ROR2 positive"
            },
            "therapy": {
                "id": 6906,
                "therapyName": "BA3021",
                "synonyms": null
            },
            "indication": {
                "id": 1115,
                "name": "sarcoma",
                "source": "DOID"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 11293,
                    "pubMedId": null,
                    "title": "Anti-tumor efficacy of BA3021, a novel Conditionally Active Biologic (CAB) anti-ROR2 ADC",
                    "url": "https://cancerres.aacrjournals.org/content/78/13_Supplement/833"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 13822,
            "approvalStatus": "Preclinical - Cell line xenograft",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, BA3021 (CAB-ROR2-ADC) inhibited growth of Ror2-positive breast cancer cells in culture and in cell line xenograft models (Proceedings of the AACR, Apr 2018, Vol 59, Abstract 833).",
            "molecularProfile": {
                "id": 29507,
                "profileName": "ROR2 positive"
            },
            "therapy": {
                "id": 6906,
                "therapyName": "BA3021",
                "synonyms": null
            },
            "indication": {
                "id": 1612,
                "name": "breast cancer",
                "source": "DOID"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 11293,
                    "pubMedId": null,
                    "title": "Anti-tumor efficacy of BA3021, a novel Conditionally Active Biologic (CAB) anti-ROR2 ADC",
                    "url": "https://cancerres.aacrjournals.org/content/78/13_Supplement/833"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 29507,
            "profileName": "ROR2 positive",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}